| 2026-07-16 | 8-K | 10.1 | Separation Agreement between Harmony Biosciences Management, Inc. and Glenn Reicin, dated July 16, 2026. |
|---|
| 2026-04-14 | 8-K | 10.2 | Executive Employment Agreement by and between Harmony Biosciences Management and Glenn Reicin, dated April 14, 2026. |
|---|
| 2026-04-14 | 8-K | 10.1 | Separation Agreement by and between Harmony Biosciences Holdings, Inc., Harmony Biosciences Management, Inc., and Sandip Kapadia, dated April 14, 2026. |
|---|
| 2026-04-02 | 8-K | 10.1 | Executive Employment Agreement between Harmony Biosciences Management, Inc. and Peter Anastasiou, dated April 2, 2026. |
|---|
| 2025-03-24 | 8-K | 10.1 | Separation Agreement by and between Jeffrey Dierks, Harmony Biosciences Holdings, Inc., Harmony Biosciences, LLC, and Harmony Biosciences Management, Inc., dated March 20, 2025. |
|---|
| 2024-05-03 | 8-K | 10.1 | Employment Letter between Harmony Biosciences, LLC, and Kumar Budur, as amended |
|---|
| 2024-04-30 | 10-Q | 10.2 | Amendment No. 2 to License and Commercialization Agreement, dated July 28, 2017, by and between Bioprojet Société Civile de Recherche and Harmony Biosciences, LLC. |
|---|
| 2024-04-30 | 10-Q | 10.1 | Amendment No. 1 to License and Commercialization Agreement, dated July 31, 2022, by and between Bioprojet Société Civile de Recherche and Harmony Biosciences, LLC. |
|---|
| 2023-10-05 | 8-K | 10.2 | Restricted Stock Unit Award Agreement dated October 4, 2023 with Jeffrey Dierks |
|---|
| 2023-10-05 | 8-K | 10.1 | Restricted Stock Unit Award Agreement dated October 4, 2023 with Sandip Kapadia |
|---|
| 2023-09-25 | 8-K | 10.1 | First Incremental Amendment dated September 21, 2023 by and among Harmony Biosciences Holdings, Inc., JPMorgan Chase Bank, N.A., as administrative agent, and Bank of America, N.A., as incremental lender |
|---|
| 2023-07-27 | 8-K | 10.3 | Pledge and Security Agreement, dated July 26, 2023, by and among Harmony Biosciences Holdings, Inc. and each of the subsidiaries of Harmony Biosciences Holdings, Inc., and JPMorgan Chase Bank, N.A., as administrative agent. |
|---|
| 2023-07-27 | 8-K | 10.2 | Guaranty, dated July 26, 2023, by and among each of the subsidiaries of Harmony Biosciences Holdings, Inc. and JPMorgan Chase Bank, N.A., as administrative agent. |
|---|
| 2023-07-27 | 8-K | 10.1 | Credit Agreement, dated as of July 26, 2023, JPMorgan Chase Bank, N.A., as administrative agent and the lenders from time to time party thereto. |
|---|
| 2023-04-24 | 8-K | 10.1 | Executive Employment Agreement, dated April 24, 2023, between Harmony Biosciences, LLC and Jeffrey M. Dayno, M.D. |
|---|
| 2023-02-21 | 10-K | 10.12.2 | Promotion Letter Agreement, dated January 23, 2023, by and between Harmony Biosciences Holdings, Inc. and Jeffrey M. Dayno, M.D. |
|---|
| 2023-02-21 | 10-K | 10.7.2 | Acknowledgment and Release Agreement, dated January 20, 2023, by and between Harmony Biosciences Holdings, Inc. and John C. Jacobs. |
|---|
| 2023-02-21 | 10-K | 10.3 | Harmony Biosciences Holdings, Inc. 2020 Incentive Award Plan, as amended by the First Amendment to the Plan, dated March 24, 2022. |
|---|
| 2023-01-23 | 8-K/A | 10.1 | Promotion Letter Agreement, dated January 23, 2023, between Harmony Biosciences Holdings, Inc. and Jeffrey M. Dayno, M.D. |
|---|
| 2022-11-01 | 10-Q | 10.2 | Amendment No. 1 to Credit Agreement, dated as of August 2, 2022, among Harmony Biosciences, Inc., as Borrower, Harmony Biosciences, LLC, as Guarantor, the Guarantors from time to time party thereto, the Lenders from time to time party thereto, and Wilmington Trust National Association, as Administrative Agent. |
|---|
| 2022-11-01 | 10-Q | 10.1 | License and Commercialization Agreement dated July 31, 2022, by and between Bioprojet Societe Civile de Recherche and Harmony Biosciences, LLC. |
|---|
| 2022-08-02 | 10-Q | 10.1 | AMENDMENT TO THE |
|---|
| 2022-05-03 | 10-Q | 10.1 | Amendment to the Harmony Biosciences Holdings, Inc. 2020 Incentive Award Plan. |
|---|
| 2021-08-10 | 10-Q | 10.3 | Pledge and Security Agreement, dated as of August 9, 2021, among Harmony Biosciences Holdings, Inc. and Harmony Biosciences, LLC, as Grantors, the other Grantors from time to time party thereto and Wilmington Trust, National Association, as Administrative Agent. |
|---|
| 2021-08-10 | 10-Q | 10.2 | Credit Agreement, dated as of August 9, 2021, among Harmony Biosciences Holdings, Inc., as Borrower, Harmony Biosciences, LLC, as Guarantor, the Guarantors from time to time party thereto, the Lenders from time to time party thereto, and Wilmington Trust, National Association, as Administrative Agent. |
|---|
| 2021-08-10 | 10-Q | 10.1 | Promotion Increase Award Letter to Jeffrey Dierks, dated June 9, 2021. |
|---|
| 2021-03-25 | 10-K | 10.20 | Offer Letter, dated September 7, 2017, by and between Harmony Biosciences, LLC and Jeffrey Dierks. |
|---|
| 2021-03-15 | 8-K | 10.1 | Employment Agreement, dated March 4, 2021, between Harmony Biosciences, LLC and Sandip Kapadia |
|---|
| 2021-03-10 | 8-K | 10.1 | Confidential Separation Agreement and General Release, between Harmony Biosciences, LLC and Susan L. Drexler, dated March 4, 2021. |
|---|
| 2020-11-12 | 10-Q | 10.9 | Harmony Biosciences Holdings, Inc. Non-Employee Director Compensation Program. |
|---|